Early Access Programmes
About
Your trusted partner
Durbin has been running Early Access and worldwide distribution programmes for pharmaceutical and biotech companies on an exclusive basis for over 20 years.
We have extensive knowledge of the regulatory requirements in the EMEA markets and rest of the world. Having run these programmes both on a compassionate and named-patient basis, we offer excellent global distribution capabilities backed up by comprehensive reporting. For complete peace of mind, our experts can also provide a consultancy and pharmacovigilance service.
